Although AMPK activities have not been studied previously in lymphoblasts from PM carriers, the relevance of AMPK expression in blood cells to neurodegenerative diseases as a biomarker and a potential molecular target in these disorders has recently been reviewed (Peixoto et al., 2017). Here, PRKAA1 is linked to neurodegenerative disease.